Ocular endpoint data is most reliable when every visit happens under consistent, controlled conditions: the right ETDRS chart distance, controllable lighting, calibrated ophthalmic equipment, and...
Read More
Many of the ocular endpoint problems 20/20 Onsite is called in to fix start in the protocol, long before the first participant sits down for an eye exam. A vague best-corrected visual acuity (BCVA)...
Read More
Yes, sponsors and CROs can set up a semi-permanent eye exam space at a research site for a long-running study. 20/20 Onsite builds these spaces through its Mobile Vision Pods (MVPs), which are...
Read More
Sponsors, CROs, and clinical operations teams evaluating a decentralized or hybrid trial have three mobile ophthalmic assessment options to choose from: a fully mobile clinic, a semi-permanent exam...
Read More
Patient recruitment is always a concern in clinical studies. More than half of clinical trials face challenges in recruiting participants. The National Institutes of Health has found that in some...
Read More
Neurology studies are highly complex trials that require the collection of substantial amounts of data. Neurology studies that rely on ophthalmic assessments need consistent, protocol-adherent...
Read More
Enrollment delays and retention failures threaten ophthalmic clinical trials. The main issue is execution barriers. Participants cannot access specialized BCVA, IOP, and OCT assessments due to the...
Read More
Accessibility barriers create enrollment failures in otherwise well-designed trials. When participants cannot reach sites due to distance, transportation limitations, mobility challenges, or...
Read More